Johnson & Johnson Innovation – JJDC (Israeli)

The strategic venture capital arm of Johnson & Johnson, investing in healthcare innovations across pharmaceuticals, medical devices, and consumer health.

Corporate VC New Brunswick, United States Est. 1973
Visit website ↗
Last updated 2026-10-28
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
—
total disclosed, rounds participated
Stages
Pre-Seed, Seed, Series A, Series B, Series C, Series D, Series E, Series F, Series G, Mature, PIPE

About

Johnson & Johnson Innovation - JJDC, Inc. (JJDC) is the strategic venture capital arm of the Johnson & Johnson Family of Companies. JJDC discovers transformative ideas and helps them mature into potential solutions for today's patients. They invest in a variety of sectors, including pharmaceutical and medtech, and at all stages, from new company creation and early-stage startups to Series A and beyond, including private investments in public equities (PIPEs).

Portfolio · 1

NovoCure
A global oncology company developing and commercializing Tumor Treating Fields (TTFields) therapy for solid tumor cancers.
Led ★ 1 round Latest: 2009-09

Q&A

What is the primary focus of Johnson & Johnson Innovation – JJDC (Israeli)?
Johnson & Johnson Innovation – JJDC (Israeli) is the strategic venture capital arm of Johnson & Johnson, focusing on healthcare innovations across pharmaceuticals, medical devices, and consumer health.
What investment stages does Johnson & Johnson Innovation – JJDC (Israeli) typically target?
Johnson & Johnson Innovation – JJDC (Israeli) invests across all stages, from new company creation and early-stage startups to Series A and beyond, including private investments in public equities (PIPEs).
What are the preferred sectors for investment by Johnson & Johnson Innovation – JJDC (Israeli)?
Johnson & Johnson Innovation – JJDC (Israeli) prefers investments in Health Tech & Life Sciences, Medical Device, Biotechnology, Pharmaceutical, and Consumer Health sectors.
What is the typical check size for investments made by Johnson & Johnson Innovation – JJDC (Israeli)?
Johnson & Johnson Innovation – JJDC (Israeli) typically invests between $1 million and $25 million per deal.
What is the total AUM for Johnson & Johnson Innovation – JJDC (Israeli)?
Johnson & Johnson Innovation – JJDC (Israeli) has a total AUM of $978,187,000.
Which geographies does Johnson & Johnson Innovation – JJDC (Israeli) prioritize for investments?
Johnson & Johnson Innovation – JJDC (Israeli) prioritizes investments in the United States, Israel, United Kingdom, Switzerland, and France.
Who are some key team members at Johnson & Johnson Innovation – JJDC (Israeli) involved in venture investments?
Key team members at Johnson & Johnson Innovation – JJDC (Israeli) include Gilad Glick, Vice President, Venture Investments, and Amir Blatt, Principal, Venture Investments.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)